Short answer
OPKO HEALTH, INC. (OPK) filed its Q3 2025 10-Q quarterly report on Oct 29, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $152M (down 12.6% year over year) with net income of $22M.
Q3 2025 key financials · XBRL
- Revenue
- $152M
- −12.6% YoY · −3.3% QoQ
- Net income
- $22M
- −13.1% YoY · +114.6% QoQ
- Operating margin
- 31.7%
- Gross margin
- 32.9%
- EPS (diluted)
- $0.05
- +66.7% YoY · +123.8% QoQ
Source: XBRL data from the OPKO HEALTH, INC. (OPK) Q3 2025 10-Q on SEC EDGAR. USD.
OPKO HEALTH, INC. Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No material risk-factor changes from the Form 10-K or March 31, 2025 Form 10-Q
- Liquidity risk: $423.732 million contractual obligations, including $246.224 million due thereafter under 2044 notes
- Funding risk: historically unsustained positive cash flow could force reduced clinical trials, research, marketing, or operations
- Regulatory and legal risk: outcomes of government investigations, payor claims, and ITA litigation could alter cash requirements
- Foreign-exchange risk: 25.2% of nine-month revenue denominated outside USD, primarily Chilean peso and euro exposure
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other OPKO HEALTH, INC. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.